Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00859014 · ClinicalTrials.gov registry record · Phase 1
Safety/Feasibility of Autologous Mononuclear Bone Marrow Cells in Stroke Patients
A Phase 1 study of Ischemic Stroke, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT00859014: Completed Phase 1 study of Ischemic Stroke, sponsored by The University of Texas Health Science Center, Houston.
NCT00859014 is a Phase 1 study of Ischemic Stroke that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 25 participants, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00859014, a Phase 1 study of Ischemic Stroke, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to find out if bone marrow treatment (bone marrow aspiration and infusion of stem cells) can be safely used in adults who have recently (within 24-72 hours)suffered an acute ischemic stroke.
Primary Outcome
Study Related Serious Adverse Events (SAE) as adjudicated by the DSMB - "Events"
Conditions Studied
Interventions
- BIOLOGICAL Autologous Bone Marrow Mononuclear Cells
Study Locations (1)
Texas
- Memorial Hermann Hospital-Medical Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2009-01 |
| Est. Completion | 2013-11 |
| Phase | Phase 1 |
What the finished NCT00859014 record still lists
NCT00859014 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Autologous Bone Marrow Mononuclear Cells is the first listed.
NCT00859014 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00859014 about?
NCT00859014 is a clinical study titled "Safety/Feasibility of Autologous Mononuclear Bone Marrow Cells in Stroke Patients". The purpose of this research study is to find out if bone marrow treatment (bone marrow aspiration and infusion of stem cells) can be safely used in adults who have recently (within 24-72 hours)suffered an acute ischemic stroke.
What is the current status of trial NCT00859014?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2009-01. Estimated completion is 2013-11.
What conditions does trial NCT00859014 study?
This clinical trial studies the following conditions: Ischemic Stroke.
What interventions are being tested in trial NCT00859014?
The interventions under investigation include: Autologous Bone Marrow Mononuclear Cells (BIOLOGICAL).
Who is sponsoring clinical trial NCT00859014?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00859014 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00859014's enrollment target sits among peer trials
25 53rd of 66 higher than 14 of 66 other Ischemic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ischemic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Verapamil for Neuroprotection in Stroke
RECRUITING · Phase 1
-
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
RECRUITING · Phase 1
-
A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS)
ACTIVE NOT RECRUITING · Phase 1
-
A Study of NCS-01 in Patients With Acute Ischemic Stroke
ACTIVE NOT RECRUITING · Phase 1
-
Functional Magnetic Resonance Imaging (fMRI) and Robot-Assisted Practice of Activities of Daily Living
COMPLETED · Phase 1
-
The Capillary Index Score Trial
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia